{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:51:14Z","timestamp":1791258674205,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-00509-22 - Demanda Universal - 01\/2022"],"award-info":[{"award-number":["APQ-00509-22 - Demanda Universal - 01\/2022"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["RED-00110-23"],"award-info":[{"award-number":["RED-00110-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.exppara.2026.109211","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:59:35Z","timestamp":1790348375000},"page":"109211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Polymeric micelle loaded with lapachol for topical treatment of mice infected with Leishmania (Leishmania) major"],"prefix":"10.1016","volume":"290","author":[{"given":"Nayara Lemes","family":"Borges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir de Deus Elian","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Ferreira","family":"Roberto da Matta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaide Braga","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Amaral","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Miranda","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-2842","authenticated-orcid":false,"given":"Marta Marques Gontijo de","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.exppara.2026.109211_bib1","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1128\/AAC.00809-10","article-title":"Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis","volume":"54","author":"Aguiar","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.exppara.2026.109211_bib2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3390\/pharmaceutics15020656","article-title":"Current advances in lipid nanosystems intended for topical and transdermal drug delivery applications","volume":"15","author":"Akombaetwa","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exppara.2026.109211_bib3","series-title":"Resoluccao RDC No 318, de 06 de Novembro de 2019. Estabelece os criterios para a realizacao de Estudos de Estabilidade de insumos farmaceuticos ativos e medicamentos, exceto biologicos, e da outras providencias","year":"2019"},{"key":"10.1016\/j.exppara.2026.109211_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exppara.2019.02.013","article-title":"Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis","volume":"199","author":"Ara\u00fajo","year":"2019","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.exppara.2026.109211_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-1263(199905\/06)19:3<163::AID-JAT561>3.0.CO;2-H","article-title":"Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release","volume":"19","author":"Arechabala","year":"1999","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.exppara.2026.109211_bib6","first-page":"1477","article-title":"Perfil hematol\u00f3gico e bioqu\u00edmico de camundongos da linhagem Balb-c [Haematological and biochemical profile of Balb-c mice]","volume":"45","author":"Barbosa","year":"2017","journal-title":"Acta Sci. Vet."},{"issue":"10151","key":"10.1016\/j.exppara.2026.109211_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.exppara.2026.109211_bib8","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1021\/acs.chemrev.8b00199","article-title":"Block copolymer micelles in nanomedicine applications","volume":"118","author":"Cabral","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.exppara.2026.109211_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejpb.2016.12.019","article-title":"Polymeric mixed micelles as nanomedicines: achievements and perspectives","volume":"113","author":"Cagel","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exppara.2026.109211_bib10","first-page":"106","article-title":"Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis","volume":"11","author":"Caridha","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"11","key":"10.1016\/j.exppara.2026.109211_bib11","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3390\/molecules27113460","article-title":"A mini-review on solid lipid nanoparticles and nanostructured lipid carriers: topical delivery of phytochemicals for the treatment of acne vulgaris","volume":"27","author":"Chutoprapat","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.exppara.2026.109211_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"issue":"7","key":"10.1016\/j.exppara.2026.109211_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ddr.21684","article-title":"Recent strategies for the development of oral medicines for the treatment of visceral leishmaniasis","volume":"81","author":"de Souza","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.exppara.2026.109211_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107413","article-title":"Recent developments of novel nanotechnology-based drug delivery systems for dermal and transdermal applications","volume":"217","author":"Erdo\u011far","year":"2026","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.exppara.2026.109211_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.exppara.2026.109211_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/pharmaceutics15010099","article-title":"Liposomal amphotericin B for treatment of leishmaniasis: from the identification of critical physicochemical attributes to the design of effective topical and oral formulations","volume":"15","author":"Fr\u00e9zard","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exppara.2026.109211_bib20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.toxrep.2021.06.021","article-title":"Curcumin-loaded nanocomplexes: acute and chronic toxicity studies in mice and hamsters","volume":"8","author":"Jantawong","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.exppara.2026.109211_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2024.106298","article-title":"Assessment of lapachol's anti-inflammatory effectiveness in mitigating sepsis-induced acute lung injury","volume":"180","author":"Joshi","year":"2025","journal-title":"Fitoterapia"},{"key":"10.1016\/j.exppara.2026.109211_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111109","article-title":"Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis","volume":"134","author":"Kawakami","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.exppara.2026.109211_bib23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1590\/S0074-02762004000700017","article-title":"Antileishmanial activity of lapachol analogues","volume":"99","author":"Lima","year":"2004","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.exppara.2026.109211_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.plantsci.2025.112659","article-title":"Lapachol, a naphthoquinone identified through chemical screening, inhibits plant immunity","volume":"359","author":"Ma","year":"2025","journal-title":"Plant Sci."},{"issue":"18","key":"10.1016\/j.exppara.2026.109211_bib25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2217\/nnm-2021-0489","article-title":"Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis","volume":"17","author":"Mansur-Alves","year":"2022","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.exppara.2026.109211_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110936","article-title":"Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model","volume":"133","author":"Mendes Miranda","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exppara.2026.109211_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biopha.2018.10.143","article-title":"In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic\u00ae F127-based polymeric micelle system against Leishmania amazonensis infection","volume":"109","author":"Mendon\u00e7a","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exppara.2026.109211_bib28","series-title":"OECD\/OCDE423 Oecd Guideline for Testingof Chemicals, Acute Oral Toxicity-Acute Toxic Class Method","year":"2001"},{"key":"10.1016\/j.exppara.2026.109211_bib29","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x2023e12693","article-title":"In vitro effects of lapachol and \u03b2-lapachone against Leishmania amazonensis","volume":"56","author":"Ramos-Milar\u00e9","year":"2023","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"17","key":"10.1016\/j.exppara.2026.109211_bib30","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/molecules25174002","article-title":"Activity of amphotericin B-Loaded chitosan nanoparticles against experimental cutaneous leishmaniasis","volume":"25","author":"Riezk","year":"2020","journal-title":"Molecules"},{"issue":"41","key":"10.1016\/j.exppara.2026.109211_bib31","doi-asserted-by":"crossref","first-page":"48514","DOI":"10.1021\/acsomega.5c06156","article-title":"Long-circulating liposomes codelivering amphotericin B and retinoic acid for cutaneous leishmaniasis treatment","volume":"10","author":"Santos","year":"2025","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.exppara.2026.109211_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/pharmaceutics16040509","article-title":"Combination of the topical photodynamic therapy of chloroaluminum phthalocyanine liposomes with fexinidazole oral self-emulsifying system as a new strategy for cutaneous leishmaniasis treatment","volume":"16","author":"Silva","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.exppara.2026.109211_bib33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1208\/s12249-018-0995-2","article-title":"Microemulsion formulations for the transdermal delivery of lapachol","volume":"19","author":"Tabosa","year":"2018","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.exppara.2026.109211_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0023677219883319","article-title":"Defining body-weight reduction as a humane endpoint: a critical appraisal","volume":"54","author":"Talbot","year":"2020","journal-title":"Lab. Anim."},{"issue":"1","key":"10.1016\/j.exppara.2026.109211_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/1099-1573(200102)15:1<44::AID-PTR685>3.0.CO;2-1","article-title":"In vitro and in vivo Leishmanicidal activity of 2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone (lapachol)","volume":"15","author":"Teixeira","year":"2001","journal-title":"Phytother Res."},{"key":"10.1016\/j.exppara.2026.109211_bib37","first-page":"129","article-title":"Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis","volume":"11","author":"Van Bocxlaer","year":"2019","journal-title":"Int. J. Parasitol.: Drugs Drug Resist."},{"issue":"4","key":"10.1016\/j.exppara.2026.109211_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1039\/D0MD00343C","article-title":"Pharmacokinetics and pharmacodynamics in the treatment of cutaneous leishmaniasis - challenges and opportunities","volume":"12","author":"Van Bocxlaer","year":"2021","journal-title":"RSC Med. Chem."},{"issue":"10","key":"10.1016\/j.exppara.2026.109211_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00631-18","article-title":"Local skin inflammation in cutaneous leishmaniasis as a source of variable pharmacokinetics and therapeutic efficacy of liposomal amphotericin B","volume":"62","author":"Wijnant","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1\u20132","key":"10.1016\/j.exppara.2026.109211_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2018.10.039","article-title":"Improvement of the skin penetration of hydrophobic drugs by polymeric micelles","volume":"553","author":"Yotsumoto","year":"2018","journal-title":"Int. J. Pharm."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489426001189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489426001189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:13:07Z","timestamp":1791256387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489426001189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":36,"alternative-id":["S0014489426001189"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2026.109211","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric micelle loaded with lapachol for topical treatment of mice infected with Leishmania (Leishmania) major","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2026.109211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109211"}}